Independent, AI-assisted research · Affiliate disclosure
HBOT Finder
article

HBOT Insurance Coverage in 2026: 14 Approved Indications Decoded

· 11 min readUpdated Jun 2026

Quick Answer

  • Medicare and most commercial insurers cover HBOT for the 14 indications in [CMS National Coverage Determination 20.29](https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=12), mirroring the [UHMS 15th Edition Indications (2025)](https://www.uhms.org/resources/hbo-indications.html).
  • Medicare Part B pays 80% of the allowed amount after the 2026 deductible of $257; patient out-of-pocket runs roughly $114 per session per the [2026 CMS Physician Fee Schedule Final Rule](https://www.cms.gov/medicare/payment/fee-schedules/physician).
  • Off-label uses (long COVID, TBI, autism, anti-aging) are almost always denied per the [FDA Safety Communication (2021, reaffirmed 2024)](https://www.fda.gov/consumers/consumer-updates/hyperbaric-oxygen-therapy-get-facts); cash prices run $250-$600 per session.
  • Prior authorization, wound-care documentation, and a treating physician referral are required at virtually every U.S. payer in 2026.

If you're staring at a stack of HBOT prescriptions wondering whether insurance pays, the short version: it depends on your ICD-10 code.

CMS covers HBOT for 14 specific indications under National Coverage Determination 20.29. Aetna, Cigna, UnitedHealthcare, and Blue Cross Blue Shield mirror that list almost word-for-word.

The result is a two-tier system. Hospital wound centers on the covered side. Cash-pay wellness clinics on the off-label side. Most patients don't know which tier they walked into until the bill shows up.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed physician before pursuing hyperbaric oxygen therapy. Coverage decisions vary by plan, state, and individual case.

What Are the 14 Covered HBOT Indications in 2026?

The list of 14 covered indications has been stable since CMS last revised NCD 20.29. Small clarifications around documentation for diabetic wounds and radiation injury were issued by Medicare Administrative Contractors in late 2025. See the late radiation tissue injury evidence atlas for the full study-by-study evidence breakdown.

Here's the full roster as recognized by both CMS and the UHMS 15th Edition Indications (2025):

  1. Acute carbon monoxide intoxication
  2. Decompression illness
  3. Gas embolism
  4. Gas gangrene (clostridial myositis and myonecrosis)
  5. Acute traumatic peripheral ischemia
  6. Crush injuries and suturing of severed limbs
  7. Progressive necrotizing infections (necrotizing fasciitis)
  8. Acute peripheral arterial insufficiency
  9. Preparation and preservation of compromised skin grafts
  10. Chronic refractory osteomyelitis
  11. Osteoradionecrosis (delayed radiation injury, bone)
  12. Soft tissue radionecrosis (delayed radiation injury, soft tissue)
  13. Cyanide poisoning
  14. Actinomycosis (adjunct when antibiotics and surgery have failed)

Diabetic wounds of the lower extremities at Wagner Grade III or higher that have failed standard care for at least 30 days are also covered. Some references count this as a 15th indication; CMS counts it as a sub-policy under NCD 20.29.

Why the List Matters More Than the Science

Coverage doesn't hinge on biology. It hinges on the ICD-10 code your physician submits.

A patient with Stage 4 radiation cystitis sails through prior authorization. A patient with post-concussion syndrome gets a flat denial even with peer-reviewed studies attached.

Emergent vs Chronic Categories

The 14 indications break into two camps.

Emergent — CO poisoning, decompression illness, gas embolism, gas gangrene, cyanide poisoning. Life-threatening situations. HBOT is delivered within hours. Coverage is automatic at any hospital with a chamber. No prior auth.

Chronic — diabetic wounds, osteoradionecrosis, refractory osteomyelitis, soft tissue radionecrosis. Outpatient wound center bread and butter. Requires 30-60 sessions, weekly documentation, and ongoing reauthorization.

How Does Medicare Cover HBOT in 2026?

Medicare is the largest single HBOT payer in the United States. Nearly all commercial insurers piggyback on the same NCD framework.

Medicare Part B — The Outpatient Workhorse

Most HBOT in 2026 is delivered in hospital outpatient wound centers, billed under Medicare Part B.

After the 2026 deductible of $257, Medicare pays 80% of the approved amount. The patient (or Medigap plan) covers the remaining 20%.

ComponentCPT Code2026 Medicare AllowedPatient 20% Share
HBOT supervision (per 30 min)99183$128.40$25.68
Hospital outpatient facility feeC1300$441.20$88.24
Total per session (typical)$569.60$113.92

Source: 2026 CMS Physician Fee Schedule and HOPPS Final Rule.

A standard 40-session course under Medicare Part B runs roughly $4,557 out of pocket. Medigap Plan G typically covers the 20% coinsurance.

Medicare Advantage — More Friction

Roughly 54% of Medicare beneficiaries are enrolled in Medicare Advantage in 2026, per Kaiser Family Foundation Medicare Advantage 2026 Enrollment Tracker.

MA plans must cover everything Original Medicare covers, but add prior authorization, narrow networks, and step-therapy. The 2024 HHS Office of Inspector General report on MA prior authorization found a meaningful share of MA denials were inappropriate under Medicare's own coverage rules. CMS partially addressed this with new turnaround-time rules effective January 2026.

Medicaid by State

Medicaid coverage in 2026 ranges from generous (California, New York, Massachusetts cover all 14 plus some off-label) to restrictive (Mississippi, Alabama, Idaho cover only emergent indications). Always verify with your state Medicaid agency before booking.

Commercial Insurance: Aetna, Cigna, BCBS, UnitedHealthcare

Commercial insurers cover the same 14 indications as Medicare in 2026. Copays, deductibles, prior auth turnaround, and network restrictions vary considerably.

Aetna (Clinical Policy Bulletin 0172)

Covers all 14 NCD indications plus idiopathic sudden sensorineural hearing loss (ISSHL) when treatment begins within 14 days of symptom onset per the Aetna Clinical Policy Bulletin 0172 (2026 update). See the sudden sensorineural hearing loss evidence atlas for the full study-by-study evidence breakdown.

Prior authorization required for any course longer than 20 sessions. Average 2026 copay: $40-$75 per session after deductible.

Cigna (Coverage Policy 0054)

Mirrors Medicare's list and explicitly excludes off-label uses including autism and chronic Lyme per the Cigna Coverage Policy 0054 (2026).

Requires detailed wound measurements every 14 days for diabetic ulcer claims. 2026 average copay: $50-$90 per session.

Blue Cross Blue Shield (varies by state)

BCBS is 33 independent plans, each with its own medical policy. Most adopt the UHMS 15th Edition list (2025) verbatim.

Pull your specific plan's policy — search for "[Your State] BCBS Hyperbaric Oxygen Medical Policy 2026."

UnitedHealthcare (Coverage Determination Guideline 2026T0540V)

Covers the 14 indications plus diabetic wounds and ISSHL per the UHC commercial coverage policy.

Strictest on documentation: TcPO2 measurement under 40 mmHg required for diabetic wound coverage; chart audits at 30-session intervals.

Big Four Comparison

PayerIndicationsAvg Copay/SessionPrior Auth
Aetna14 + ISSHL$40-$75Above 20 sessions
Cigna14 only$50-$90Always
BCBS (national avg)14 + ISSHL (most plans)$45-$110Always
UnitedHealthcare14 + ISSHL$55-$95Always

What Does HBOT Cost Without Insurance?

The 2026 national average for a single 90-minute session at a private clinic runs $250-$600 depending on market.

Pricing by Setting

SettingAvg Cost/Session 202640-Session CourseNotes
Hospital wound center (in-network)$114 patient share$4,557After Medicare/insurance
Hospital wound center (cash)$1,500-$2,000$60,000-$80,000Almost no one pays this
Standalone private clinic$250-$450$10,000-$18,000Most common cash setting
Wellness/longevity clinic$400-$600$16,000-$24,000Higher-end markets
Mild HBOT (1.3 ATA, soft chamber)$100-$150$4,000-$6,000Not FDA-cleared for medical claims

The gap between hospital list price and cash-clinic price is one of the strangest pricing oddities in US healthcare. Hospitals charge $1,800+ per session because that's what they bill insurance. They almost never collect that from cash patients.

Pros and Cons of Cash-Pay HBOT

Pros: Access to off-label treatment, no prior authorization delays, more flexible scheduling, often newer chambers.

Cons: $10,000-$25,000 typical out-of-pocket for a full course, no HSA/FSA reimbursement without a Letter of Medical Necessity, variable accreditation, no guarantee of clinical benefit for off-label uses.

Why Off-Label HBOT Isn't Covered

This is the question that frustrates patients most.

FDA Clearance and CMS National Coverage

CMS will not add an indication to NCD 20.29 without strong, repeated, randomized evidence. The bar is typically two or more well-designed Phase 3 trials with consistent positive results.

No off-label condition has cleared this bar for an NCD update since the 2017 ISSHL recognition.

UHMS Endorsement

The UHMS 15th Edition Indications (2025) is the de facto standard for what counts as evidence-based HBOT. Off-label uses lacking UHMS endorsement face an uphill battle even in external appeals.

Payer Cost Modeling

Even with strong evidence, payers run actuarial models on coverage expansion costs. Adding TBI as a covered indication would expose payers to billions in new annual claims.

Common Off-Label Requests and Coverage Reality

Off-Label ConditionCoverage Status 2026Typical Out-of-Pocket
Traumatic brain injury (TBI)Denied (except active-duty via DoD)$13,000-$24,000
Long COVID / post-acute COVIDDenied$12,000-$20,000
Autism spectrum disorderDenied$10,000-$18,000
Chronic Lyme diseaseDenied$14,000-$22,000
Stroke recovery (chronic phase)Denied$15,000-$25,000
Anti-aging / longevityDenied$18,000-$30,000
Sports injury recoveryDenied$5,000-$12,000

How to Get HBOT Approved in 2026

Step 1: Right Diagnosis Code

Your treating physician documents an ICD-10 code mapping to one of the 14 covered indications. For diabetic wounds, this means E11.621 plus Wagner Grade III or higher documented. For radiation tissue damage, T66.XXXA with confirmed history of therapeutic radiation.

Step 2: Pre-Authorization Workup

Most payers require:

  • 30+ days of documented standard wound care (diabetic ulcers)
  • Vascular studies (TcPO2 < 40 mmHg, ABI < 0.8)
  • Failed conservative therapy notes
  • Specialist referral (vascular surgery, infectious disease, or wound care)
  • Recent labs (HbA1c < 12% for diabetic patients in most plans)

Step 3: Submit Prior Authorization

Your wound care center handles this. Average 2026 turnaround:

  • Medicare traditional: 0 days (no prior auth required for covered indications)
  • Medicare Advantage: roughly 5 days (per CMS rule effective January 2026)
  • Aetna: 3-7 days
  • Cigna: 5-10 days
  • UnitedHealthcare: 7-14 days
  • BCBS: 5-12 days (varies)

Step 4: Document Every Session

Each treatment must include TcPO2 readings, wound measurements, photographs, vital signs, and chamber pressure logs. Missing documentation is the leading cause of post-payment audits and clawbacks.

Step 5: Reassess at 30 Sessions

Insurers require documented re-evaluation showing measurable progress before authorizing sessions 31-60.

If You Get Denied

  1. Internal appeal — submit within 30-60 days with additional clinical documentation
  2. Peer-to-peer review — physician requests a direct call with the payer's medical director
  3. External appeal — file with your state Department of Insurance
  4. State insurance commissioner complaint — useful for clear NCD policy violations

Hospital vs Private Clinic Coverage

The single biggest factor in whether HBOT is covered isn't your diagnosis. It's where you receive treatment.

Roughly 89% of insurance-covered HBOT in 2026 is delivered in hospital-based wound centers per the UHMS Facility Accreditation Manual (2023).

Hospital-Based Wound Centers

The gold standard for covered care. Typically Healogics, RestorixHealth, or hospital-employed teams. Rigorous UHMS accreditation. Insurance loves them for the documentation infrastructure.

Pros: In-network, multidisciplinary care, accredited, lowest out-of-pocket.

Cons: Slower scheduling (4-12 week waits common), older equipment in some markets, limited weekend hours.

Private Standalone Clinics

Primarily cash-pay off-label. Increasingly accept insurance for covered indications.

Pros: Faster scheduling, modern equipment, more flexible hours, often cover off-label cases.

Cons: Higher out-of-pocket for off-label uses, variable accreditation, some operate without UHMS facility designation.

What to Look For in Any Setting

  • UHMS Facility Accreditation
  • Board-certified hyperbaric physician (UHM subspecialty or ABPM)
  • Certified Hyperbaric Technologist (CHT) operating the chamber
  • Class A hard-shell chamber for medical claims per FDA classification
  • Documented emergency protocols and on-site oxygen safety

Network Status Is Everything

Even when a private clinic accepts insurance, the question is whether they're in-network with your specific plan. Out-of-network HBOT providers will sometimes bill insurance and balance-bill you for the difference. Always ask: "Are you in-network with my specific plan?" "Will you submit prior authorization on my behalf?" "What's my expected out-of-pocket per session?"

Frequently Asked Questions

Does Medicare cover HBOT for long COVID in 2026?

No. Medicare does not cover HBOT for long COVID, post-acute sequelae of SARS-CoV-2 (PASC), or any post-viral fatigue syndrome as of 2026. Long COVID is not on NCD 20.29. Despite promising trials including the sham-controlled study published in Zilberman-Itskovich et al., Scientific Reports 2022, CMS has not added long COVID. Patients pursuing this treatment pay roughly $10,000-$20,000 out of pocket at private clinics.

How many HBOT sessions will insurance approve at a time?

Most payers initially approve 20-30 sessions, with reauthorization required for additional treatment. Medicare typically authorizes up to 60 total sessions for diabetic wounds without case-by-case review. Complex cases like osteoradionecrosis can extend to 90+ sessions with documented progress. Reauthorization requires documented improvement in wound size, TcPO2, or symptom severity per the UHMS 15th Edition Indications (2025).

Can I use my HSA or FSA to pay for off-label HBOT?

Yes, but only with a Letter of Medical Necessity from your physician. The IRS allows HSA/FSA reimbursement for HBOT when prescribed for a specific medical condition, even if insurance doesn't cover it, per IRS Publication 502 (2024). Save the LMN, treatment receipts, and clinical notes. Without an LMN, the IRS may classify the spending as ineligible and trigger penalty taxes.

Does the VA cover HBOT for veterans with TBI or PTSD?

Partially. The Department of Veterans Affairs began offering HBOT for service-connected mild TBI under a pilot program in 2017, which expanded to all VA medical centers with hyperbaric capability in 2023. Veterans with documented service-connected mTBI or treatment-resistant PTSD can access up to 40 HBOT sessions through the VA, though wait times average roughly 90 days at major VA medical centers per the VA Office of Inspector General Hyperbaric Medicine Access Audit (2024). Active-duty service members can access HBOT through DoD programs with shorter wait times.

What's the difference between HBOT and "mild HBOT" for insurance purposes?

Insurance only covers treatment delivered in Class A hard-shell chambers at 2.0-2.5 ATA with 100% medical-grade oxygen. "Mild HBOT" at 1.3 ATA in soft-shell chambers is not FDA-cleared as a medical device and is never covered by insurance. The FDA Safety Communication (2021, reaffirmed 2024) explicitly addresses this distinction. Always verify chamber type and ATA before booking.

The Bottom Line

HBOT insurance coverage in 2026 is more reliable than ever if your condition is on the list. The 14 covered indications represent decades-validated medicine and the reimbursement infrastructure works.

If you're pursuing HBOT for an off-label reason — TBI, long COVID, autism, longevity — walk in with eyes open. The gate is real, the evidence bar is high, and the financial commitment lands on your family.

The next decade will likely bring at least one or two new indications onto the covered list. Long COVID and chronic mild TBI are the strongest candidates if current trials replicate.

Related Reading

Find HBOT Centers Near You

Browse our directory of UHMS-accredited HBOT centers to find a facility in-network with your specific plan.


-- The HBOT Finder Team

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Coverage decisions vary by plan, state, and individual case. Always consult a licensed physician and verify benefits directly with your insurer before pursuing HBOT.

Editorial Disclosure: HBOT Finder maintains editorial independence. We do not accept paid placements in our clinic directory.

Find a Clinic

Why are you considering hyperbaric oxygen therapy?

Related Articles

Stay in the loop

Get the latest articles delivered to your inbox.